Impact of COVID-19 on Psoriasis Practice
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04581044|
Recruitment Status : Completed
First Posted : October 9, 2020
Last Update Posted : November 13, 2020
COVID-19 had a major impact on dermatology practice globally with special emphasis on chronic diseases e.g. psoriasis. The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis management.
This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian dermatologists.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||197 participants|
|Official Title:||Impact of COVID-19 on Psoriasis Practice: A Cross Sectional Study|
|Actual Study Start Date :||September 17, 2020|
|Actual Primary Completion Date :||October 23, 2020|
|Actual Study Completion Date :||October 23, 2020|
- Questionnaire to assess 1) Prescription pattern for Psoriasis patients during COVID-19 2) Management pattern for Psoriasis patients during COVID-19 [ Time Frame: 2-4 weeks ]
- Questionnaire to assess 1) Impact of COVID-19 on the course of psoriasis in patients 2) Impact of COVID-19 on the psoriasis patients behaviour [ Time Frame: 2-4 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04581044
|Department of Dermatology, Cairo University|